Source: Arjun Walia
- The Facts:Multiple companies have started clinical trials and testing of potential vaccines for the new coronavirus.
- Reflect On:Vaccine hesitancy is at an all time high, will the coronavirus be mandatory, and what will be the penalty for those who refuse?
Special Note To Our Readers: We are concerned that our Facebook Page will be deleted, so we are encouraging all those who want to continue to receive and be able to find our content to sign up for our email list. Thank you.
The coronavirus is taking the world by storm, and many pharmaceutical companies are in a race to develop the vaccine that will be put into circulation for the public. Obviously, it takes some time to develop a vaccine, usually just over a year, but there have been some initiatives put in place to potentially fast-track the coronavirus vaccine. We will have to wait and see.
As of now, media outlets are reporting on multiple developments. For example, tests in mice of a potential vaccine for the new coronavirus have shown that it does indeed induce an immune response against it, at levels that could possibly prevent infection. According to Global News,
A team at the University of Pittsburgh School of Medicine in the United States said they were able to move quickly in developing a potential COVID-19 vaccine after working on other coronaviruses that cause Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS).
Forbes is reporting that the second phase of human trials for a new vaccine from Moderna may start this spring. Moderna’s cofounder and chairman Noubar Afeyan told CNBC that, while it’s challenging to put a timetable on the vaccine’s progress, “We expect [phase two trials] to happen in the spring, perhaps early summer.”
The second phase involves expanding to hundreds of people in different groups based on certain characteristics like age and physical health. The third phase is potentially the last with the vaccine being given to thousands of people to test its efficacy and safety. Many vaccines also go through a fourth phase after they’ve been approved and licensed.